7. Influence of Background
Parenchymal Enhancement
• Greater BPE may negatively influence breast
MRI performances (DeMartini, AJR 2012 536 patients
versus 200 patients)
– Decreasing specificity : increase of abnormal exam (30% vs 23%)
– No significant difference in positive rate of biopsy, cancer yield
• In the analysis of breast cancers not diagnosed
at MRI : less misdiagnosis of detection than caraterisation
Mistakes detection not influenced by BPE (Bouic-Pages Radiology
2012)
• BPE influenced by
hormonal fluctuation ,HRT, or Tamoxifen
34. Non-Mass Enhancement
Enhancing area that is not a mass , separate
from background parenchymal enhancement
may contain interspersed fat
– Distribution (symetric or asymetric)
– Internal enhancement characteristics
– T2 weighted signal intensity
35. Fat area or normal parenchyma inside enhancement
49. Ring Enhancement
PPV of malignancy = 70-100%
Ductal carcinoma
invasive cancer associated with
ductal carcinoma in situ
Uematsu AJR 2012 Non masse 3T
Tozaki AJR 2006
54. Associated findings
•
•
•
•
•
•
•
Nipple or skin retraction
Skin thickening ( focal or diffuse)
Edema
Lymphadenopathy
Pectoralis muscle involvement
Precontrast increased ductal signal intensity
Susceptibility artifact related to surgical clips
55.
56.
57.
58. Implants
• Material type : silicone, saline
• Location: retro-glandular or retropectoral
• Intra or extra-capsular rupture
59. Using new lexicon
• PPV for malignancy:mass
– Irregular shape and margin
– Spiculated
– Ring sign
– Heterogeneous
– Wash out kinetics
• PPV for malignancy : non mass
– Distribution : linear branching and segmental
– Internal enhancement : clumped and
clustered ring
60. Breast MRI interpretation
• BI-RADS IRM
– 0 : if suspicion of benign lesion (ex : FA)
– 4 : biopsy recommended ( even if US performed for
choice of the guidance)
– 3 (PPV variable in MRI)
• Global BI-RADS : combined reporting with
mammography / US
61. Conclusion
• T2 weighted sequence
• Background parenchymal enhancement
• Masses / non masses enhancement :
simplification
• Breast implant
• Management / facilitation patient care : BIRADS
0, 4, 3
• BIRADS global